Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia
出版年份 2020 全文链接
标题
Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia
作者
关键词
-
出版物
LEUKEMIA & LYMPHOMA
Volume -, Issue -, Pages 1-3
出版商
Informa UK Limited
发表日期
2020-06-06
DOI
10.1080/10428194.2020.1772476
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview
- (2019) Michele Baccarani et al. LEUKEMIA
- Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study
- (2019) Aytug Kizilors et al. Lancet Haematology
- Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission
- (2019) Ilaria S. Pagani et al. LEUKEMIA
- Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
- (2019) Timothy P. Hughes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre
- (2018) Ya-Zhen Qin et al. BRITISH JOURNAL OF HAEMATOLOGY
- BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
- (2018) Ilaria S Pagani et al. HAEMATOLOGICA
- BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
- (2018) Ilaria S Pagani et al. HAEMATOLOGICA
- Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells
- (2018) David M. Ross et al. LEUKEMIA
- The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
- (2017) Andrew A. Wylie et al. NATURE
- The concept of treatment-free remission in chronic myeloid leukemia
- (2016) S Saußele et al. LEUKEMIA
- FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
- (2014) Aaron M. Newman et al. BIOINFORMATICS
- Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation
- (2014) Cristian A. Ferri et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients
- (2013) D M Ross et al. LEUKEMIA
- Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features
- (2011) D. M. Ross et al. HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More